Data / Drug companies / Dr. Reddy's Laboratories Inc.
Dr. Reddy's Laboratories Inc.: 9 products in the FDA NDC directory, labeler code 55741
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Dr. Reddy's Laboratories Inc. (labeler code 55741) lists 9 products in the FDA National Drug Code Directory, covering 5 finished drugs by generic name. By type: 8 over the counter drugs, 1 prescription drugs. Its main marketing category is new drug applications (NDA). The newest product started marketing on February 13, 2026.
The request: Watch Dr. Reddy's Laboratories Inc. (FDA labeler code 55741): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 55741
- Products in commercial distribution
- 9
- Packages
- 20
- Finished drugs by generic name
- 5
- Prescription products
- 1
- Over the counter products
- 8
- Flagged as original packager
- 9 of 9 products that carry the flag
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- May 14, 2015
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| New drug applications (NDA) | 4 | 44.4% |
| Generic drugs (ANDA) | 3 | 33.3% |
| Over the counter monograph drugs | 2 | 22.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 8 | 88.9% |
| Prescription drugs | 1 | 11.1% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Nicotine transdermal system patch | 3 | 2 |
| Magnesium salicylate | 2 | 4 |
| Nicotine polacrilex | 2 | 57 |
| Nicotine | 1 | 37 |
| Levonorgestrel and ethinyl estradiol | 1 | 19 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Patch, extended release | 3 | 33.3% |
| Tablet | 2 | 22.2% |
| Gum, chewing | 2 | 22.2% |
| Kit | 2 | 22.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Cholinergic Nicotinic Agonist | 5 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Lutera | 55741-005 | Kit | Generic drugs (ANDA) | February 13, 2026 |
| Habitrol Nicotine Polacrilex 2 mg Coated Cinnamon | 55741-004 | Gum, chewing | Generic drugs (ANDA) | July 28, 2025 |
| Habitrol Nicotine Polacrilex 4 mg Coated Cinnamon | 55741-001 | Gum, chewing | Generic drugs (ANDA) | July 28, 2025 |
| Habitrol Step 1 | 55741-448 | Patch, extended release | New drug applications (NDA) | July 13, 2018 |
| Habitrol Step 2 | 55741-447 | Patch, extended release | New drug applications (NDA) | July 13, 2018 |
| Habitrol Step 3 | 55741-446 | Patch, extended release | New drug applications (NDA) | July 13, 2018 |
| Doans Maximum Strength | 55741-600 | Tablet | Over the counter monograph drugs | May 24, 2016 |
| Doans Extra Strength | 55741-224 | Tablet | Over the counter monograph drugs | May 24, 2016 |
| Nicotine transdermal system | 55741-449 | Kit | New drug applications (NDA) | May 14, 2015 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.